Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung

Lignende værker

• Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib
  af: CHEN, YUH-MIN, et al.
  Udgivet: (2011)
• Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations
  af: WU, WEN-SHUO, et al.
  Udgivet: (2012)
• Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
  af: Chen, Yuh-Min, et al.
  Udgivet: (2004)
• Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients
  af: Tseng, Yen-Han, et al.
  Udgivet: (2015)
• Evaluation of the Relative Cytotoxic Effects of Anticancer Agents in Serum‐supplemented versus Serum‐free Media Using a Tetrazolium Colorimetric Assay
  af: Tsai, Chun‐Ming, et al.
  Udgivet: (1996)